Vice President, U.S. Market Access & Pricing

Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Vice President, Market Access will lead the strategy and execution of all market access activities to support the successful launch of the company’s adult pneumococcal vaccine. Reporting to the Chief Commercial Officer, this role will be accountable for ensuring broad, timely, and sustainable access across public and private channels. As Vaxcyte prepares for its first commercial launch, the VP will operate as a hands-on leader, building foundational capabilities while directly shaping payer, provider, and policy environments. This role requires a balance of strategic leadership and execution, with a particular focus on navigating the unique access dynamics of adult vaccines, including public health recommendations, buy-and-bill reimbursement, and site-of-care considerations. Essential Functions: Lead development and execution of the U.S. market access strategy for the adult pneumococcal vaccine, including pricing, reimbursement, contracting, and channel strategy Define and drive launch readiness plans aligned to regulatory approval and immunization guideline milestones (e.g., ACIP or other recommending bodies) Shape access strategies across commercial payers, Medicare, Medicaid, and public health channels Develop and execute engagement strategies for key stakeholders, including GPOs, IDNs, retail pharmacy, and public health entities Establish pricing strategy and gross-to-net assumptions, ensuring alignment with vaccine-specific market dynamics Ensure readiness for coding, coverage, reimbursement, and provider economics within buy-and-bill and pharmacy settings Partner with Medical Affairs to define and deliver HEOR and value evidence to support payer and policy decision-making Serve as the market access lead across cross-functional teams, aligning with Commercial, Medical, Regulatory, Government Affairs, and Finance Build and lead a lean market access function, leveraging external partners to scale capabilities efficiently Working cross functionally, prepare for CDC immunization program, state immunization program, and ACIP-adjacent policy stakeholder engagements; translate ACIP recommendation language into access and coverage implications across all channels Develop and execute integrated PBM, commercial payer, and Medicare Part B and D contracting strategies to ensure optimal formulary positioning, coverage, and patient access across channels. Support development of national retail pharmacy and alternate vaccination site strategies, establishing partnerships that maximize vaccine availability, administration, and uptake. Develop scenario-based access, reimbursement, and customer adoption strategies aligned to potential ACIP recommendation outcomes and evolving adult immu